Willie O'Dea
Question:409. Deputy Willie O'Dea asked the Minister for Health further to Parliamentary Question No. 279 of 22 October 2019, if osimertinib for adult patients with locally advanced or metastatic EGFRT790M mutation-positive non-small cell lung cancer will be made available from 1 January 2020; if the HSE senior leadership team has discussed the reimbursement of the drug for adult patients with same subsequent to its decision of 9 July 2019 that it was minded to approve the drug; and if he will make a statement on the matter. [47536/19]
View answer